SUPPLEMENT SCIENCEInsights
Search

Search Insights

Try choline, nano-curcumin or probiotics.

    Botanical guide · Ingredient reference

    Reishi and cancer: what human studies can and cannot show

    Human reishi research includes small studies of immune responses and other preliminary outcomes. It does not establish reishi as a cancer cure or a replacement for standard treatment. The National Cancer Institute notes that reishi is not FDA-approved to treat cancer.

    Read the evidence ↓

    Supplement Science Insights Editorial Team

    Published September 23, 2026

    Human research exists, but the question matters

    NCI describes studies of reishi products used alongside cancer care, including research on immune responses in people with lung cancer. Such findings can motivate further trials, but a changed immune-cell measurement is not the same as improved survival or proven tumor control. [1]

    Adjunctive studies do not test replacement treatment

    Some participants received chemotherapy, radiation or other treatments at the same time. An observation in that setting does not show what reishi would do by itself. MSK concludes that further research is needed to establish its safety and effectiveness as an adjunct in cancer care. [1][2]

    Benign growths and cancer are different endpoints

    NCI also summarizes research on benign colorectal tumors using a specific mycelial preparation. That is not proof that a retail reishi powder treats established colorectal cancer. Keep the population, preparation and outcome attached to the result rather than generalizing every tumor-related observation into a cure claim. [1]

    Do not substitute evidence from another mushroom

    NCI separately discusses turkey-tail-derived PSK and its use with cancer treatment in Japan. PSK findings do not automatically apply to reishi, a mushroom coffee or an uncharacterized turkey tail powder. The named preparation and treatment context are essential. [1]

    Treatment and laboratory interactions need review

    MSK cautions about bleeding risk, immune-related interactions and possible effects involving cancer treatments. Reishi spore products can also affect the tumor marker CA72-4. Tell the oncology team what you are taking before interpreting a changed result or starting a supplement. [2]

    Ask for the patient-important outcome

    Imagine an advertisement cites improved immune markers and promises cancer remission. Ask whether that exact product improved survival, symptoms or tumor outcomes in appropriate controlled human research. The inspected summaries do not justify abandoning standard treatment on that basis. [1][2]

    Hypothetical example — interpret a hypothetical reishi cancer claim
    FindingLimit
    Immune marker changeNot proof of survival benefit
    Adjunctive useNot replacement treatment
    Benign adenoma outcomeNot established cancer treatment
    Different mushroom extractNot interchangeable evidence
    Reishi and cancer: what human studies can and cannot show — original article outline diagram
    Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

    Sources for this article

    1. Mushrooms - NCI
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.
    2. Reishi Mushroom | Memorial Sloan Kettering Cancer Center
      Source consulted: 2026-09-21. This is a reference resource, not a claim that we conducted the studies or tested a product.